薬史学雑誌
Online ISSN : 2435-7529
Print ISSN : 0285-2314
ISSN-L : 0285-2314
我が国において抗生物質医薬品の品質基準の果たした役割に関する薬史学的・公衆衛生学的考察:第2報 ペニシリン及びストレプトマイシンの国産化の達成
八木澤 守正Patrick J. Foster黒川 達夫
著者情報
ジャーナル フリー

2015 年 50 巻 2 号 p. 131-142

詳細
抄録
Domestic production of penicillin was initiated in 1946 and that of streptomycin in 1950. In the early days, however, the quality of products was considerably lower and the capacity of production small. Surprisingly, there was a sufficient amount of penicillin preparations, with a purity of 85% or more, satisfying domestic demand within three years (1949). In the case of streptomycin, within three years (1953), preparations with a purity two-fold higher than initially available were produced in amounts sufficient to meet both domestic demand and create a surplus availability for exporting purposes. Such increases in quality and production were considered to be made possible by strict quality control of penicillin and streptomycin preparations, based on Minimum Requirements for Penicillin established in May 1947 and Minimum Requirements for Streptomycin established in December 1949. These requirements were also amended over time in order to provide even higher quality standards in response to the evolving improvements in production processes. Life-threatening diseases such as septicemia and pneumonia were controlled by the sufficient supply of high-quality penicillin preparations and the mortality rate of tuberculosis, regarded as a national disease at the time, markedly decreased by that of streptomycin preparations. Achievements of domestic production of penicillin and streptomycin were considered important factors that contributed greatly to the maintenance of public health in Japan. PMID: 27149779 [Indexed for MEDLINE]
著者関連情報
© 2015 日本薬史学会
前の記事 次の記事
feedback
Top